We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · July 15, 2020

Late Transplant–Associated Thrombotic Microangiopathy in Allogeneic Hematopoietic Stem Cell Transplantation

American Journal of Hematology


Additional Info

American Journal of Hematology
Characteristics of Late Transplant-Associated Thrombotic Microangiopathy (TA-TMA) in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Am. J. Hematol 2020 Jul 02;[EPub Ahead of Print], C Heybeli, M Sridharan, HB Alkhateeb, JJ Villasboas Bisneto, FK Buadi, D Chen, D Dingli, A Dispenzieri, MA Gertz, RS Go, SK Hashmi, SR Hayman, W Hogan, DJ Inwards, SS Kenderian, SK Kumar, MR Litzow, LF Porrata, MQ Lacy, IN Micallef, MS Patnaik, MV Shah, N Leung

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading